Markets:

Overview

News

Currencies

International

Treasuries

Medipharm Labs Corp (OP:MEDIF)

0.0435 -0.0023 (-5.02%)

Delayed Quote Updated: 2:36 PM EST, Nov 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 3 4 5 6 Next >

MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30% ↗

April 13, 2023

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow

Via Benzinga

The Canadian Cannabis Report - Monday, April 10 ↗

April 10, 2023

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.

Via Talk Markets

MediPharm Labs FY22 Revenue Grows Slightly To $16.3M ↗

March 31, 2023

MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021.

Via Benzinga

MediPharm Labs Shareholders Approve Merger With VIVO Cannabis ↗

March 22, 2023

MediPharm Labs Corp.

Via Benzinga

Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit ↗

March 21, 2023

Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to...

Via Benzinga

MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice ↗

July 27, 2022

MediPharm Labs Corp.

Via Benzinga

MediPharm Labs To Acquire VIVO Cannabis ↗

December 22, 2022

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc.

Via Benzinga

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

December 22, 2022

Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets...

Via Newsfile

Topics Cannabis

The Canadian Cannabis Report - Monday, Dec. 19 ↗

December 19, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Nov.28 ↗

November 28, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Nov. 21 ↗

November 21, 2022

The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally ↗

November 14, 2022

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended Sept. 30, 2022.

Via Benzinga

The Canadian Cannabis Report - Monday, Nov. 14 ↗

November 14, 2022

The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Aug. 29 ↗

August 29, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, Aug. 15 ↗

August 15, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details ↗

August 15, 2022

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021.

Via Benzinga

The Canadian Cannabis Report - Monday, Aug. 1 ↗

August 01, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, July 25 ↗

July 25, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility ↗

July 11, 2022

MediPharm Labs Corp.

Via Benzinga

The Canadian Cannabis Report - Monday, June 20 ↗

June 20, 2022

The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

BREAKING: Brazil Supreme Court Authorizes Citizens To Grow Medicinal Cannabis ↗

June 14, 2022

What Happened?

Via Benzinga

The Canadian Cannabis Report- Monday, May 23 ↗

May 23, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

The Canadian Cannabis Report - Monday, May 16 ↗

May 16, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

MediPharm Labs Q1 Revenue Slightly Drops, Here Are The Details ↗

May 16, 2022

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) revenue decreased 11.24% to $4.88 million in Q1 2022 compared to $5.5 million in Q1 2021.

Via Benzinga

The Canadian Cannabis Report - Monday, May 9 ↗

May 09, 2022

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.

Via Talk Markets

Cannabis Movers & Shakers: SuperNet, MediPharm, Le-Vel, Jupiter Wellness, Leafly, Acreage ↗

April 22, 2022

SuperNet Names John Pfisterer As CFO SuperNet, a payment network that enables credit card payments for cannabis merchants and consumers, has tapped John Pfisterer to oversee its financial department.

Via Benzinga

MediPharm Labs Launches CBG And Water-Soluble CBN:THC Products ↗

April 05, 2022

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX: LABS) (FSE: MLZ) launched CBG and water-soluble products. As of today, these new products will be available in Ontario in both retail stores and on the OCS...

Via Benzinga

MediPharm Labs Reports Fourth Quarter And Full Year 2021 Results, International Sales Double To $9.5M ↗

March 31, 2022

MediPharm Labs Corp. (OTC: MEDIF) a pharmaceutical company specializing in precision-based cannabinoids, announced on Thursday its financial results for the Fourth Quarter and Full-Year that ended on...

Via Benzinga

MediPharm Labs Acquires Shelter Cannabis Brands' IP To Expand Portfolio With Flower And Pre-Rolls ↗

March 22, 2022

MediPharm Labs Corp. (OTCQX:MEDIF) (TSXV:

Via Benzinga

MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF ↗

February 23, 2022

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.